NICE backs insulin pump therapy

Insulin pump therapy has been approved for patients with type-1 diabetes, according to preliminary NICE guidance.

Both children and adults with difficult to control type-1 diabetes could be eligible for continuous subcutaneous insulin infusion (CSII).

But patients with type-2 diabetes cannot be given the therapy.

Under-11s can be given the treatment if multiple-dose insulin (MDI) therapy is inappropriate and the child or carers are considered competent to use CSII.

Older patients are eligible for CSII if they find it impossible to maintain a HbA1c of 8.5 per cent or less using MDI or they suffer from recurrent and unpredictable hypoglycaemic events, says NICE.

CSII uses an external pump to continuously deliver insulin to the patient. It can be programmed to ensure insulin is delivered at higher rates at meal times, or has different basal rates in the day or night.

The NICE appraisal committee says evidence shows CSII has a valuable effect on HbA1c levels and can reduce the rate of hypoglycaemic episodes.

CSII can only be initiated by specialist teams, says NICE.

rachel.liddle@haymarket.com

Comment below and tell us what you think 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

COVID-19 death rate highest among BAME groups, delayed PHE review confirms

COVID-19 death rate highest among BAME groups, delayed PHE review confirms

Death rates from COVID-19 are highest among patients from BAME groups, according...

GPs face hundreds of complaints over shielding and PPE during pandemic

GPs face hundreds of complaints over shielding and PPE during pandemic

GP practices have faced hundreds of complaints over issues including shielding and...

More than 3,600 GP partners lost in four years as decline accelerates

More than 3,600 GP partners lost in four years as decline accelerates

The number of full-time equivalent (FTE) GP partners in England fell by 3,636 between...

COVID-19 pandemic leaves 2.4m patients stuck in cancer care backlog

COVID-19 pandemic leaves 2.4m patients stuck in cancer care backlog

Around 2.4m patients are waiting longer for cancer tests or treatment because of...

PHE report delayed on how ethnicity affects COVID-19 outcomes

PHE report delayed on how ethnicity affects COVID-19 outcomes

Public Health England (PHE) has missed its 31 May deadline for reporting on how factors...

Lockdown complacency threatens second COVID-19 spike that could 'overwhelm' NHS

Lockdown complacency threatens second COVID-19 spike that could 'overwhelm' NHS

Complacency around easing coronavirus lockdown measures could trigger a second wave...